Ligand validation:6HRO

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6HRO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HRO_NAG_A_601	51%	85%	0.156	0.909	0.23	0.51	-	-	0	0	100%	0.9333
6HRO_NAG_A_602	49%	81%	0.139	0.884	0.31	0.51	-	-	0	0	100%	0.9333
6HRO_NAG_B_701	1%	78%	0.533	0.759	0.43	0.46	-	-	0	0	100%	0.9333
6HRO_NAG_A_603	1%	50%	0.525	0.742	0.89	1.04	1	1	0	0	100%	0.9333
6HRO_NAG_A_604	1%	83%	0.587	0.674	0.3	0.48	-	-	0	0	100%	0.9333
6F6S_NAG_B_701	79%	82%	0.128	0.974	0.29	0.5	-	-	0	0	100%	0.9333
6G9I_NAG_A_601	77%	83%	0.118	0.958	0.26	0.52	-	-	0	0	100%	0.9333
7SSR_NAG_A_601	75%	78%	0.112	0.945	0.34	0.54	-	-	0	0	100%	0.9333
7LYD_NAG_A_601	75%	72%	0.124	0.957	0.28	0.77	-	1	0	0	100%	0.9333
6F6N_NAG_A_501	72%	86%	0.133	0.958	0.21	0.51	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.